 | • レポートコード：GIR-107A14986 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、遺伝子治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。遺伝子治療薬の種類別市場規模（神経筋疾患、遺伝病、その他）、用途別市場規模（病院、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・遺伝子治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：F. Hoffmann-La Roche AG、Novartis International AG、Gilead Sciences, Inc.、Ultragenyx Pharmaceutical，Inc.、Applied Genetic Technologies Corp、Audentes Therapeutics、BioMarin Pharmaceutical、Bluebird Bio、Nightstar Therapeutics、Sangamo Therapeutics、Spark Therapeutics、uniQure、VBL Therapeutics、Voyager Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：神経筋疾患、遺伝病、その他 ・用途別分析2016年-2026年：病院、薬局 ・遺伝子治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・遺伝子治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・遺伝子治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・遺伝子治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・遺伝子治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gene Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gene Therapy Drugs size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Gene Therapy Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gene Therapy Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Neuromuscular Disease
Genetic Disease
Other
Market segment by Application, can be divided into
Hospital
Pharmacy
Market segment by players, this report covers
F. Hoffmann-La Roche AG
Novartis International AG
Gilead Sciences, Inc.
Ultragenyx Pharmaceutical，Inc.
Applied Genetic Technologies Corp
Audentes Therapeutics
BioMarin Pharmaceutical
Bluebird Bio
Nightstar Therapeutics
Sangamo Therapeutics
Spark Therapeutics
uniQure
VBL Therapeutics
Voyager Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Gene Therapy Drugs
1.2 Classification of Gene Therapy Drugs by Type
1.2.1 Overview: Global Gene Therapy Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gene Therapy Drugs Revenue Market Share by Type in 2020
1.2.3 Neuromuscular Disease
1.2.4 Genetic Disease
1.2.5 Other
1.3 Global Gene Therapy Drugs Market by Application
1.3.1 Overview: Global Gene Therapy Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Gene Therapy Drugs Market Size & Forecast
1.5 Global Gene Therapy Drugs Market Size and Forecast by Region
1.5.1 Global Gene Therapy Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gene Therapy Drugs Market Size by Region, (2016-2021)
1.5.3 North America Gene Therapy Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Gene Therapy Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gene Therapy Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Gene Therapy Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gene Therapy Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Therapy Drugs Market Drivers
1.6.2 Gene Therapy Drugs Market Restraints
1.6.3 Gene Therapy Drugs Trends Analysis
2 Company Profiles
2.1 F. Hoffmann-La Roche AG
2.1.1 F. Hoffmann-La Roche AG Details
2.1.2 F. Hoffmann-La Roche AG Major Business
2.1.3 F. Hoffmann-La Roche AG Gene Therapy Drugs Product and Solutions
2.1.4 F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans
2.2 Novartis International AG
2.2.1 Novartis International AG Details
2.2.2 Novartis International AG Major Business
2.2.3 Novartis International AG Gene Therapy Drugs Product and Solutions
2.2.4 Novartis International AG Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis International AG Recent Developments and Future Plans
2.3 Gilead Sciences, Inc.
2.3.1 Gilead Sciences, Inc. Details
2.3.2 Gilead Sciences, Inc. Major Business
2.3.3 Gilead Sciences, Inc. Gene Therapy Drugs Product and Solutions
2.3.4 Gilead Sciences, Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Gilead Sciences, Inc. Recent Developments and Future Plans
2.4 Ultragenyx Pharmaceutical，Inc.
2.4.1 Ultragenyx Pharmaceutical，Inc. Details
2.4.2 Ultragenyx Pharmaceutical，Inc. Major Business
2.4.3 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product and Solutions
2.4.4 Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Ultragenyx Pharmaceutical，Inc. Recent Developments and Future Plans
2.5 Applied Genetic Technologies Corp
2.5.1 Applied Genetic Technologies Corp Details
2.5.2 Applied Genetic Technologies Corp Major Business
2.5.3 Applied Genetic Technologies Corp Gene Therapy Drugs Product and Solutions
2.5.4 Applied Genetic Technologies Corp Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Applied Genetic Technologies Corp Recent Developments and Future Plans
2.6 Audentes Therapeutics
2.6.1 Audentes Therapeutics Details
2.6.2 Audentes Therapeutics Major Business
2.6.3 Audentes Therapeutics Gene Therapy Drugs Product and Solutions
2.6.4 Audentes Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Audentes Therapeutics Recent Developments and Future Plans
2.7 BioMarin Pharmaceutical
2.7.1 BioMarin Pharmaceutical Details
2.7.2 BioMarin Pharmaceutical Major Business
2.7.3 BioMarin Pharmaceutical Gene Therapy Drugs Product and Solutions
2.7.4 BioMarin Pharmaceutical Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 BioMarin Pharmaceutical Recent Developments and Future Plans
2.8 Bluebird Bio
2.8.1 Bluebird Bio Details
2.8.2 Bluebird Bio Major Business
2.8.3 Bluebird Bio Gene Therapy Drugs Product and Solutions
2.8.4 Bluebird Bio Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bluebird Bio Recent Developments and Future Plans
2.9 Nightstar Therapeutics
2.9.1 Nightstar Therapeutics Details
2.9.2 Nightstar Therapeutics Major Business
2.9.3 Nightstar Therapeutics Gene Therapy Drugs Product and Solutions
2.9.4 Nightstar Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Nightstar Therapeutics Recent Developments and Future Plans
2.10 Sangamo Therapeutics
2.10.1 Sangamo Therapeutics Details
2.10.2 Sangamo Therapeutics Major Business
2.10.3 Sangamo Therapeutics Gene Therapy Drugs Product and Solutions
2.10.4 Sangamo Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sangamo Therapeutics Recent Developments and Future Plans
2.11 Spark Therapeutics
2.11.1 Spark Therapeutics Details
2.11.2 Spark Therapeutics Major Business
2.11.3 Spark Therapeutics Gene Therapy Drugs Product and Solutions
2.11.4 Spark Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Spark Therapeutics Recent Developments and Future Plans
2.12 uniQure
2.12.1 uniQure Details
2.12.2 uniQure Major Business
2.12.3 uniQure Gene Therapy Drugs Product and Solutions
2.12.4 uniQure Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 uniQure Recent Developments and Future Plans
2.13 VBL Therapeutics
2.13.1 VBL Therapeutics Details
2.13.2 VBL Therapeutics Major Business
2.13.3 VBL Therapeutics Gene Therapy Drugs Product and Solutions
2.13.4 VBL Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 VBL Therapeutics Recent Developments and Future Plans
2.14 Voyager Therapeutics
2.14.1 Voyager Therapeutics Details
2.14.2 Voyager Therapeutics Major Business
2.14.3 Voyager Therapeutics Gene Therapy Drugs Product and Solutions
2.14.4 Voyager Therapeutics Gene Therapy Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Voyager Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Therapy Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Therapy Drugs Players Market Share
3.2.2 Top 10 Gene Therapy Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Gene Therapy Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gene Therapy Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Gene Therapy Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gene Therapy Drugs Revenue Market Share by Application (2016-2021)
5.2 Gene Therapy Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gene Therapy Drugs Revenue by Type (2016-2026)
6.2 North America Gene Therapy Drugs Revenue by Application (2016-2026)
6.3 North America Gene Therapy Drugs Market Size by Country
6.3.1 North America Gene Therapy Drugs Revenue by Country (2016-2026)
6.3.2 United States Gene Therapy Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Gene Therapy Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Gene Therapy Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gene Therapy Drugs Revenue by Type (2016-2026)
7.2 Europe Gene Therapy Drugs Revenue by Application (2016-2026)
7.3 Europe Gene Therapy Drugs Market Size by Country
7.3.1 Europe Gene Therapy Drugs Revenue by Country (2016-2026)
7.3.2 Germany Gene Therapy Drugs Market Size and Forecast (2016-2026)
7.3.3 France Gene Therapy Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gene Therapy Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Gene Therapy Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Gene Therapy Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gene Therapy Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Gene Therapy Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Gene Therapy Drugs Market Size by Region
8.3.1 Asia-Pacific Gene Therapy Drugs Revenue by Region (2016-2026)
8.3.2 China Gene Therapy Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Gene Therapy Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Gene Therapy Drugs Market Size and Forecast (2016-2026)
8.3.5 India Gene Therapy Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gene Therapy Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Gene Therapy Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gene Therapy Drugs Revenue by Type (2016-2026)
9.2 South America Gene Therapy Drugs Revenue by Application (2016-2026)
9.3 South America Gene Therapy Drugs Market Size by Country
9.3.1 South America Gene Therapy Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Gene Therapy Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Gene Therapy Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gene Therapy Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Gene Therapy Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Gene Therapy Drugs Market Size by Country
10.3.1 Middle East & Africa Gene Therapy Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Gene Therapy Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gene Therapy Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Gene Therapy Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Gene Therapy Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gene Therapy Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gene Therapy Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gene Therapy Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gene Therapy Drugs Revenue Market Share by Region (2021-2026)
Table 6. F. Hoffmann-La Roche AG Corporate Information, Head Office, and Major Competitors
Table 7. F. Hoffmann-La Roche AG Major Business
Table 8. F. Hoffmann-La Roche AG Gene Therapy Drugs Product and Solutions
Table 9. F. Hoffmann-La Roche AG Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis International AG Corporate Information, Head Office, and Major Competitors
Table 11. Novartis International AG Major Business
Table 12. Novartis International AG Gene Therapy Drugs Product and Solutions
Table 13. Novartis International AG Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Gilead Sciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Gilead Sciences, Inc. Major Business
Table 16. Gilead Sciences, Inc. Gene Therapy Drugs Product and Solutions
Table 17. Gilead Sciences, Inc. Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Ultragenyx Pharmaceutical，Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Ultragenyx Pharmaceutical，Inc. Major Business
Table 20. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Product and Solutions
Table 21. Ultragenyx Pharmaceutical，Inc. Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Applied Genetic Technologies Corp Corporate Information, Head Office, and Major Competitors
Table 23. Applied Genetic Technologies Corp Major Business
Table 24. Applied Genetic Technologies Corp Gene Therapy Drugs Product and Solutions
Table 25. Applied Genetic Technologies Corp Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Audentes Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Audentes Therapeutics Major Business
Table 28. Audentes Therapeutics Gene Therapy Drugs Product and Solutions
Table 29. Audentes Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. BioMarin Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 31. BioMarin Pharmaceutical Major Business
Table 32. BioMarin Pharmaceutical Gene Therapy Drugs Product and Solutions
Table 33. BioMarin Pharmaceutical Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bluebird Bio Corporate Information, Head Office, and Major Competitors
Table 35. Bluebird Bio Major Business
Table 36. Bluebird Bio Gene Therapy Drugs Product and Solutions
Table 37. Bluebird Bio Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Nightstar Therapeutics Corporate Information, Head Office, and Major Competitors
Table 39. Nightstar Therapeutics Major Business
Table 40. Nightstar Therapeutics Gene Therapy Drugs Product and Solutions
Table 41. Nightstar Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Sangamo Therapeutics Corporate Information, Head Office, and Major Competitors
Table 43. Sangamo Therapeutics Major Business
Table 44. Sangamo Therapeutics Gene Therapy Drugs Product and Solutions
Table 45. Sangamo Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
Table 47. Spark Therapeutics Major Business
Table 48. Spark Therapeutics Gene Therapy Drugs Product and Solutions
Table 49. Spark Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. uniQure Corporate Information, Head Office, and Major Competitors
Table 51. uniQure Major Business
Table 52. uniQure Gene Therapy Drugs Product and Solutions
Table 53. uniQure Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. VBL Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. VBL Therapeutics Major Business
Table 56. VBL Therapeutics Gene Therapy Drugs Product and Solutions
Table 57. VBL Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Voyager Therapeutics Corporate Information, Head Office, and Major Competitors
Table 59. Voyager Therapeutics Major Business
Table 60. Voyager Therapeutics Gene Therapy Drugs Product and Solutions
Table 61. Voyager Therapeutics Gene Therapy Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Global Gene Therapy Drugs Revenue (USD Million) by Players (2019-2021)
Table 63. Global Gene Therapy Drugs Revenue Share by Players (2019-2021)
Table 64. Breakdown of Gene Therapy Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Gene Therapy Drugs Players Head Office, Products and Services Provided
Table 66. Gene Therapy Drugs Mergers & Acquisitions in the Past Five Years
Table 67. Gene Therapy Drugs New Entrants and Expansion Plans
Table 68. Global Gene Therapy Drugs Revenue (USD Million) by Type (2016-2021)
Table 69. Global Gene Therapy Drugs Revenue Share by Type (2016-2021)
Table 70. Global Gene Therapy Drugs Revenue Forecast by Type (2021-2026)
Table 71. Global Gene Therapy Drugs Revenue by Application (2016-2021)
Table 72. Global Gene Therapy Drugs Revenue Forecast by Application (2021-2026)
Table 73. North America Gene Therapy Drugs Revenue by Type (2016-2021) & (USD Million)
Table 74. North America Gene Therapy Drugs Revenue by Type (2021-2026) & (USD Million)
Table 75. North America Gene Therapy Drugs Revenue by Application (2016-2021) & (USD Million)
Table 76. North America Gene Therapy Drugs Revenue by Application (2021-2026) & (USD Million)
Table 77. North America Gene Therapy Drugs Revenue by Country (2016-2021) & (USD Million)
Table 78. North America Gene Therapy Drugs Revenue by Country (2021-2026) & (USD Million)
Table 79. Europe Gene Therapy Drugs Revenue by Type (2016-2021) & (USD Million)
Table 80. Europe Gene Therapy Drugs Revenue by Type (2021-2026) & (USD Million)
Table 81. Europe Gene Therapy Drugs Revenue by Application (2016-2021) & (USD Million)
Table 82. Europe Gene Therapy Drugs Revenue by Application (2021-2026) & (USD Million)
Table 83. Europe Gene Therapy Drugs Revenue by Country (2016-2021) & (USD Million)
Table 84. Europe Gene Therapy Drugs Revenue by Country (2021-2026) & (USD Million)
Table 85. Asia-Pacific Gene Therapy Drugs Revenue by Type (2016-2021) & (USD Million)
Table 86. Asia-Pacific Gene Therapy Drugs Revenue by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Gene Therapy Drugs Revenue by Application (2016-2021) & (USD Million)
Table 88. Asia-Pacific Gene Therapy Drugs Revenue by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Gene Therapy Drugs Revenue by Region (2016-2021) & (USD Million)
Table 90. Asia-Pacific Gene Therapy Drugs Revenue by Region (2021-2026) & (USD Million)
Table 91. South America Gene Therapy Drugs Revenue by Type (2016-2021) & (USD Million)
Table 92. South America Gene Therapy Drugs Revenue by Type (2021-2026) & (USD Million)
Table 93. South America Gene Therapy Drugs Revenue by Application (2016-2021) & (USD Million)
Table 94. South America Gene Therapy Drugs Revenue by Application (2021-2026) & (USD Million)
Table 95. South America Gene Therapy Drugs Revenue by Country (2016-2021) & (USD Million)
Table 96. South America Gene Therapy Drugs Revenue by Country (2021-2026) & (USD Million)
Table 97. Middle East & Africa Gene Therapy Drugs Revenue by Type (2016-2021) & (USD Million)
Table 98. Middle East & Africa Gene Therapy Drugs Revenue by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Gene Therapy Drugs Revenue by Application (2016-2021) & (USD Million)
Table 100. Middle East & Africa Gene Therapy Drugs Revenue by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Gene Therapy Drugs Revenue by Country (2016-2021) & (USD Million)
Table 102. Middle East & Africa Gene Therapy Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gene Therapy Drugs Picture
Figure 2. Global Gene Therapy Drugs Revenue Market Share by Type in 2020
Figure 3. Neuromuscular Disease
Figure 4. Genetic Disease
Figure 5. Other
Figure 6. Gene Therapy Drugs Revenue Market Share by Application in 2020
Figure 7. Hospital Picture
Figure 8. Pharmacy Picture
Figure 9. Global Gene Therapy Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Gene Therapy Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Gene Therapy Drugs Revenue Market Share by Region (2016-2026)
Figure 12. Global Gene Therapy Drugs Revenue Market Share by Region in 2020
Figure 13. North America Gene Therapy Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Gene Therapy Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Gene Therapy Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Gene Therapy Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Gene Therapy Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Gene Therapy Drugs Market Drivers
Figure 19. Gene Therapy Drugs Market Restraints
Figure 20. Gene Therapy Drugs Market Trends
Figure 21. F. Hoffmann-La Roche AG Recent Developments and Future Plans
Figure 22. Novartis International AG Recent Developments and Future Plans
Figure 23. Gilead Sciences, Inc. Recent Developments and Future Plans
Figure 24. Ultragenyx Pharmaceutical，Inc. Recent Developments and Future Plans
Figure 25. Applied Genetic Technologies Corp Recent Developments and Future Plans
Figure 26. Audentes Therapeutics Recent Developments and Future Plans
Figure 27. BioMarin Pharmaceutical Recent Developments and Future Plans
Figure 28. Bluebird Bio Recent Developments and Future Plans
Figure 29. Nightstar Therapeutics Recent Developments and Future Plans
Figure 30. Sangamo Therapeutics Recent Developments and Future Plans
Figure 31. Spark Therapeutics Recent Developments and Future Plans
Figure 32. uniQure Recent Developments and Future Plans
Figure 33. VBL Therapeutics Recent Developments and Future Plans
Figure 34. Voyager Therapeutics Recent Developments and Future Plans
Figure 35. Global Gene Therapy Drugs Revenue Share by Players in 2020
Figure 36. Gene Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Gene Therapy Drugs Revenue Market Share in 2020
Figure 38. Global Top 10 Players Gene Therapy Drugs Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Gene Therapy Drugs Revenue Share by Type in 2020
Figure 41. Global Gene Therapy Drugs Market Share Forecast by Type (2021-2026)
Figure 42. Global Gene Therapy Drugs Revenue Share by Application in 2020
Figure 43. Global Gene Therapy Drugs Market Share Forecast by Application (2021-2026)
Figure 44. North America Gene Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 45. North America Gene Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 46. North America Gene Therapy Drugs Revenue Market Share by Country (2016-2026)
Figure 47. United States Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Gene Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 51. Europe Gene Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 52. Europe Gene Therapy Drugs Revenue Market Share by Country (2016-2026)
Figure 53. Germany Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Gene Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Gene Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Gene Therapy Drugs Revenue Market Share by Region (2016-2026)
Figure 61. China Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Gene Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 68. South America Gene Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 69. South America Gene Therapy Drugs Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Gene Therapy Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Gene Therapy Drugs Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Gene Therapy Drugs Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Gene Therapy Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の中枢神経系疾患用遺伝子治療市場 2021：企業別、地域別、種類・用途別 The Gene Therapy for CNS Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界の遺伝子治療市場予測（～2024年） Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, t…
- 世界の遺伝子治療製品市場 2021：企業別、地域別、種類・用途別 The Gene Therapy Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界のがんホルモン療法剤市場 2021：企業別、地域別、種類・用途別 The Cancer Hormone Therapy Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の腫瘍学における遺伝子治療市場予測（～2024年）：企業別、地域別、種類・用途別 Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. Scope of the Report: The global Gene Therapy in Oncology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a…